Capricor Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CAPR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
20 Sep 24	BuyUS$14,999,998	Nippon Shinyaku Co., Ltd.	Company		2,798,507	US$5.36

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CAPR?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	570,699	1.26%
Public Companies	4,944,429	10.9%
Institutions	8,412,237	18.5%
General Public	31,542,543	69.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 47.7%.

Top Shareholders

Top 25 shareholders own 27.97% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.9%	Nippon Shinyaku Co., Ltd.	4,944,429	US$64.6m	130%	no data
3.85%	BlackRock, Inc.	1,750,007	US$22.9m	7.46%	no data
3.47%	The Vanguard Group, Inc.	1,576,541	US$20.6m	1.78%	no data
1.4%	Geode Capital Management, LLC	638,189	US$8.3m	-0.53%	no data
1.13%	State Street Global Advisors, Inc.	512,313	US$6.7m	27.8%	no data
0.74%	Superstring Capital Management LP	337,347	US$4.4m	0%	4.76%
0.66%	Ikarian Capital, LLC	300,000	US$3.9m	0%	1.16%
0.63%	Altium Capital Management LP	285,000	US$3.7m	0%	1.19%
0.59%	Northern Trust Global Investments	268,071	US$3.5m	107%	no data
0.55%	Point72 Asset Management, L.P.	250,204	US$3.3m	0%	0.01%
0.52%	Advisor Group Holdings, Inc., Asset Management Arm	235,550	US$3.1m	45.1%	0.04%
0.44%	Linda Marbán	199,524	US$2.6m	0%	no data
0.39%	Frank Litvack	179,547	US$2.3m	34.7%	no data
0.34%	PFM Health Sciences, LP	152,779	US$2.0m	0%	0.13%
0.28%	Morgan Stanley, Investment Banking and Brokerage Investments	127,345	US$1.7m	62.6%	no data
0.27%	Ghost Tree Capital, LLC	125,000	US$1.6m	0%	0.64%
0.27%	Susquehanna International Group, LLP, Asset Management Arm	123,412	US$1.6m	205%	no data
0.22%	Jane Street Group, LLC, Asset Management Arm	99,126	US$1.3m	441%	no data
0.21%	Millennium Management LLC	94,757	US$1.2m	-80.2%	no data
0.21%	StemPoint Capital LP	93,638	US$1.2m	0%	0.42%
0.2%	Schonfeld Strategic Advisors LLC	90,365	US$1.2m	0%	0.01%
0.2%	David Musket	88,788	US$1.2m	62.1%	no data
0.19%	Boothbay Fund Management, LLC	87,750	US$1.1m	0%	0.04%
0.18%	UBS O'Connor LLC	82,900	US$1.1m	0%	0.1%
0.16%	Charles Schwab Investment Management, Inc.	73,468	US$960.2k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 02:29
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Capricor Therapeutics, Inc. is covered by 10 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kristen Kluska	Cantor Fitzgerald & Co.
Reni Benjamin	H.C. Wainwright & Co.
Joseph Pantginis	H.C. Wainwright & Co.